Spain· ES:1262040008
JASCAYD 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing nerandomilast, registered in Spain by Boehringer Ingelheim International Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- nerandomilast
- Manufacturer
- Boehringer Ingelheim International Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- July 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nerandomilast in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJASCAYDBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- United StatesJASCAYDBoehringer Ingelheim Pharmaceuticals, Inc.
- IrelandJascayd 18 mg film-coated tabletsBoehringer Ingelheim International GmbH
- BelgiumJascayd 18 mgBoehringer Ingelheim International
- PolandJascaydBoehringer Ingelheim International GmbH
- SwedenJascayd 18 mg Filmdragerad tablettBoehringer Ingelheim International GmbH
- NetherlandsJascayd 18 mg filmomhulde tablettenBoehringer Ingelheim International GmbH
- FinlandJascaydBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jascayd
- Liechtenstein · Jascayd
- Norway · Jascayd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be4f9310-22ae-4d8f-bb56-22e3feed1104 GET /v1/drugs/be4f9310-22ae-4d8f-bb56-22e3feed1104?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1784805245000}",
"nregistro": "1262040008",
"substance": "nerandomilast"
}See everything about nerandomilast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.